Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T07:26:53.649Z Has data issue: false hasContentIssue false
  • English
  • Français

Intravenous tPA for acute stroke

Published online by Cambridge University Press:  21 May 2015

Gord Gubitz  and
Steve Phillips
Gord Gubitz
Affiliation:
Neurology, [email protected]
Steve Phillips
Affiliation:
Neurology, [email protected], Queen Elizabeth II Health Sciences Centre, Halifax, NS

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters • Courrier
Information
Canadian Journal of Emergency Medicine , Volume 3 , Issue 1 , January 2001 , pp. 5
Copyright
Copyright © Canadian Association of Emergency Physicians 2001

References

1.Rhine, D.Intravenous tPA for acute stroke: Any and all hospitals? Any and all docs? CJEM 2000; 2(3):189–91.CrossRefGoogle ScholarPubMed
2.Katzan, IL, Furlan, AJ, Lloyd, LE, Frank, JI, Harper, DL, Hinchley, JA, et al. Use of tissue-type plasminogen activator for acute stroke: the Cleveland area experience. JAMA 2000;283(9):1151–8.CrossRefGoogle ScholarPubMed
3.Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333(24):1581–7.Google Scholar
4.Wardlaw, JM, del Zoppo, G, Yamaguchi, T. Thrombolytic therapy in acute ischaemic stroke. Part 1: Thrombolysis versus control. Oxford: Update Software. The Coch-rane Library 2000: issue 2.Google Scholar
5.Gubitz, G, Sandercock, P, Counsell, C, Signorini, D. Anticoagulants for acute ischaemic stroke. Oxford: Update Software. The Cochrane Library 2000: issue 2.Google Scholar